Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H. Hagedorn

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Immunology|March 6, 2010
Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodiesPeter H Hagedorn, Christopher M Burton, Jørn Carlsen, et al.
Nucleic Acid Therapeutics|August 20, 2013
Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification patternPeter H Hagedorn, Victor Yakimov, Søren Ottosen, et al.
Nucleic Acids Research|May 24, 2018
Identifying and avoiding off-target effects of RNase H-dependent antisense oligonucleotides in micePeter H Hagedorn, Malene Pontoppidan, Tina S Bisgaard, et al.
Nucleic Acid Therapeutics|February 15, 2022
Acute Neurotoxicity of Antisense Oligonucleotides After Intracerebroventricular Injection Into Mouse Brain Can Be Predicted from Sequence FeaturesPeter H Hagedorn, Jeffrey M Brown, Amy Easton, et al.
Drug Discovery Today|October 10, 2017
Locked nucleic acid: modality, diversity, and drug discoveryPeter H Hagedorn, Robert Persson, Erik D Funder, et al.
Nucleic Acid Therapeutics|February 6, 2025
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry RecommendationsPatrik Andersson, Sebastien A Burel, Heather Estrella, et al.
Cell Cycle (Georgetown, Tex.)|May 17, 2013
STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphomaKatharina L Kopp, Ulrik Ralfkiaer, Lise Mette R Gjerdrum, et al.
Molecular Therapy. Nucleic Acids|February 26, 2020
Allele-Selective Knockdown of MYH7 Using Antisense OligonucleotidesBrian R Anderson, Marianne L Jensen, Peter H Hagedorn, et al.
Cell Metabolism|September 25, 2012
Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic β cell fate in response to cytokinesJakob Bondo Hansen, Morten Fog Tonnesen, Andreas Nygaard Madsen, et al.
Blood|August 26, 2011
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Ulrik Ralfkiaer, Peter H Hagedorn, Nannie Bangsgaard, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Immunology|March 6, 2010
Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodiesPeter H Hagedorn, Christopher M Burton, Jørn Carlsen, et al.
Nucleic Acid Therapeutics|August 20, 2013
Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification patternPeter H Hagedorn, Victor Yakimov, Søren Ottosen, et al.
Nucleic Acids Research|May 24, 2018
Identifying and avoiding off-target effects of RNase H-dependent antisense oligonucleotides in micePeter H Hagedorn, Malene Pontoppidan, Tina S Bisgaard, et al.
Nucleic Acid Therapeutics|February 15, 2022
Acute Neurotoxicity of Antisense Oligonucleotides After Intracerebroventricular Injection Into Mouse Brain Can Be Predicted from Sequence FeaturesPeter H Hagedorn, Jeffrey M Brown, Amy Easton, et al.
Drug Discovery Today|October 10, 2017
Locked nucleic acid: modality, diversity, and drug discoveryPeter H Hagedorn, Robert Persson, Erik D Funder, et al.
Nucleic Acid Therapeutics|February 6, 2025
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry RecommendationsPatrik Andersson, Sebastien A Burel, Heather Estrella, et al.
Cell Cycle (Georgetown, Tex.)|May 17, 2013
STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphomaKatharina L Kopp, Ulrik Ralfkiaer, Lise Mette R Gjerdrum, et al.
Molecular Therapy. Nucleic Acids|February 26, 2020
Allele-Selective Knockdown of MYH7 Using Antisense OligonucleotidesBrian R Anderson, Marianne L Jensen, Peter H Hagedorn, et al.
Cell Metabolism|September 25, 2012
Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic β cell fate in response to cytokinesJakob Bondo Hansen, Morten Fog Tonnesen, Andreas Nygaard Madsen, et al.
Blood|August 26, 2011
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Ulrik Ralfkiaer, Peter H Hagedorn, Nannie Bangsgaard, et al.
Pageof 4